Gain Therapeutics, Inc. SEC filings GANX
Gain Therapeutics, Inc. has 240 filings in SEC EDGAR's recent list, going back to Jul 30, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 28, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Other events
|
Jul 16, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Nov 28, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 17, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 10, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 15, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Other events
|
Oct 21, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 8, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 6, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 12, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 28, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 8, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2024 | Feb 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 31, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 22, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Agreement ended
|
Nov 17, 2023 | Nov 17, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 12, 2023 | Apr 6, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 20, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2022 | Mar 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 28, 2021 | Dec 23, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 20, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Other events
|
May 4, 2021 | May 3, 2021 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Mar 22, 2021 | Mar 17, 2021 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GANX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1819411
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.